Allergan shares are down 0.6% in late day trading, which is off the stock's earlier lows after news that Mylan Pharmaceuticals (MYL) filed a Petition requesting an inter partes review of a patent held by Allergan.
I hope my screed last week about frothy dry bulk carrier stocks persuaded you not to get into that thicket—or to sell out if you had been lured in. The group, led by Dryships, which we sold ages ago, duly crashed.
Whatever Trump’s opinion, the overwhelming “Yes” vote on Nov. 8 just. unleashed a tsunami of cash. That tsunami is heading in the direction of marijuana companies – and in the direction of those companies’ investors.